Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2010
06/22/2010US7741446 Fusion antibodies that cross the blood-brain barrier in both directions
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741444 Neoplasm specific antibodies and uses thereof
06/22/2010US7741443 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases
06/22/2010US7741442 Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
06/22/2010US7741440 Apoptin-associating protein
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
06/22/2010US7741288 serine/threonine phosphatases (PP1); immobilization, screening
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741276 Use of interleukin-18 inhibitors to inhibit tumor metastasis
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741114 using monoclonal antibody to selectively isolate and/or characterize particular cell populations such as haematopoietic stem , neuronal, mesenchymal stem and progenitor cells
06/22/2010US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/22/2010US7741072 Polypeptide variants
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7741055 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing
06/22/2010US7741053 antibody that binds to a metal ion-affinity peptide having a high affinity for coordinated metals and also being highly antigenic
06/22/2010US7741050 autoantibodies which recognize extracellular structures of G protein-coupled receptors; autoimmune diseases; Raynaud's syndrome, cardiomyopathy, myocarditis, hypertension
06/22/2010US7741039 Postweaning multisystemic wasting syndrome virus from pigs
06/22/2010US7741024 used as immunogens to elicit immune reaction, screening assays, including as antigens to screen antibody libraries, as well as for drug screening and the identification of ligands
06/22/2010US7741021 Detecting and modulating post-translational O-sulfonation of serine and threonine residues on polypeptides
06/22/2010US7740869 Phep, an amino acid permease of Staphylococcus aureus
06/22/2010US7740852 Binding molecules capable of neutralizing rabies virus and uses thereof
06/22/2010US7740851 Ultra high affinity neutralizing antibodies
06/22/2010US7740850 PDGFRβ-specific antibodies
06/22/2010US7740847 humanized anti-CD20 antibodies comprising a human IgG1 Fc region; for treating lymphoma
06/22/2010US7740845 Reducing tumor cells; isolated nucleic acids, proteins, peptides, cells, vectors, liposomes, antibodies, transgenic animals; drug screening; imaging, diagnosis
06/22/2010US7740844 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy
06/22/2010US7740843 Human monoclonal antibodies against human IL-4
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740841 Therapeutic method for reducing angiogenesis
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2518746C Method and compositions for improving animal health
06/22/2010CA2497883C Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
06/22/2010CA2369672C Transgenic animals expressing salivary proteins
06/22/2010CA2347973C Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
06/22/2010CA2337491C Human mink gene mutations associated with arrhythmia
06/22/2010CA2295577C Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumors originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
06/22/2010CA2256483C P13 lipid kinase
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/22/2010CA2175893C Protein tyrosine kinases named rse
06/22/2010CA2122745C Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumor-selective therapy
06/17/2010WO2010068923A2 Agents that selectively inhibit cd25 on dendritic cells or t cells and their use
06/17/2010WO2010068747A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
06/17/2010WO2010068722A1 Crystals and structure of a human igg fc variant with enhanced fcrn binding
06/17/2010WO2010068437A1 Isoform specific anti-her4 antibodies
06/17/2010WO2010068278A2 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
06/17/2010WO2010067611A1 ANTIBODY AGAINST N-TERMINAL REGION OF β-CHAIN OF HEMOGLOBIN
06/17/2010WO2010067308A2 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
06/17/2010WO2010067286A2 IgE CH3 PEPTIDE VACCINE
06/17/2010WO2010066914A2 Remedies for pemphigus containing anti fas ligand antibodies
06/17/2010WO2010066872A1 A monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therapy
06/17/2010WO2010066868A2 Anti-igf antibodies
06/17/2010WO2010066836A2 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
06/17/2010WO2010066835A2 Eph receptor and ephrin ligand interaction
06/17/2010WO2010066803A2 Human antibodies aganist tissue factor.
06/17/2010WO2010066762A1 Antibody formulation
06/17/2010WO2010066689A2 Organic compounds
06/17/2010WO2010066051A1 Thiol-nota derivatives for kit 68ga radiolabeling
06/17/2010WO2010066018A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010WO2010065995A1 Isolated vegf-c and vegf-d peptides and uses thereof
06/17/2010WO2010048190A3 Antibodies that bind to il-12 and methods of purifying the same
06/17/2010WO2010046775A3 Methods for producing antibodies from plasma cells
06/17/2010WO2009142773A8 Multivalent fibronectin based scaffold domain proteins
06/17/2010WO2009140972A3 Modulation of the vps10p-domain receptors for the treatment of cardiovascular disease
06/17/2010WO2009101059A3 Methods of using cadherin 11 (cdh11) antagonists
06/17/2010US20100154071 Fxdy5 modulators for treating, diagnosing, and detecting cancer
06/17/2010US20100152427 Nucleic acid encoding a novel dp receptor protein and methods of use thereof
06/17/2010US20100152426 Apo-2 receptor fusion proteins
06/17/2010US20100152425 Material for Separation of a Biomolecule
06/17/2010US20100152421 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
06/17/2010US20100152109 Influenza inhibiting compositions and methods
06/17/2010US20100152095 Wound healing
06/17/2010US20100151589 Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof
06/17/2010US20100151581 Purification of immunoglobulins
06/17/2010US20100151566 Recombinant antibodies against the vascular endothelial growth factor (vegf)
06/17/2010US20100151524 Compositions and Methods for Increasing Bone Mineralization
06/17/2010US20100151523 Regulated expression of recombinant proteins from adeno-associated viral vectors
06/17/2010US20100151503 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer
06/17/2010US20100151500 Compositions, Devices, Kits and Methods for Detecting Hookworm
06/17/2010US20100151495 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
06/17/2010US20100151486 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
06/17/2010US20100151483 Reagents for the detection of protein phosphorylation in signaling pathways
06/17/2010US20100151247 Precipitation Stabilising Compositions
06/17/2010US20100151024 Therapeutic agent for ulcerative colitis
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/17/2010US20100150965 Dna promoters and anthrax vaccines
06/17/2010US20100150956 Multicomponent vaccines
06/17/2010US20100150950 Human antibodies that bind cd70 and uses thereof
06/17/2010US20100150947 Tolerance induction and maintenance in hematopoietic stem cell allografts
06/17/2010US20100150945 Anti-mdl-1 antibodies
06/17/2010US20100150941 Hemagglutinin antibody and uses thereof
06/17/2010US20100150940 Anti-igf antibodies
06/17/2010US20100150939 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 1494